[{"indications": "Indications\u00a0Wilson\u2019s disease in patients intolerant of penicillamine", "name": "TRIENTINE DIHYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.8 Metabolic disorders", "9.8.1 Drugs used in metabolic disorders", "Wilson\u2019s disease", "TRIENTINE DIHYDROCHLORIDE"], "cautions": "Cautions\u00a0\n(From Wilson\u2019s disease: British National Formulary)\nTrientine is used for the treatment of Wilson\u2019s disease only in patients intolerant of penicillamine; it is not an alternative to penicillamine for rheumatoid arthritis or cystinuria. Penicillamine-induced systemic lupus erythematosus may not resolve on transfer to trientine.; interactions: Appendix 1 (trientine)", "side-effects": "Side-effects\u00a0nausea, rash; very rarely anaemia;\r\nduodenitis and colitis also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5180.htm", "doses": ["adult and child over 12 years, 1.2\u20132.4\u00a0g daily in 2\u20134 divided\r\ndoses before food; child 2\u201312 years,\r\ninitially 0.6\u20131.5\u00a0g daily in 2\u20134 divided doses before food, adjusted\r\naccording to response"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk; monitor maternal and neonatal serum-copper concentration;\r\nteratogenic in animal studies"}]